|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 22, 2018 ) The Global Zika Virus Vaccines Market was worth USD 14.5 billion in 2017 and estimated to be growing at a CAGR of 5.4%, to reach USD 18.86 billion by 2022. Zika virus is a mosquito borne fever caused by Aedes mosquitoes when they are active in the day-time. It is similar to the yellow fever, West Nile virus and dengue. Zika vaccines are developed in order to prevent and control diseases caused by zika virus. This disease has no symptoms or sometimes very mild symptoms like minimal form of dengue fever, skin rash and joint pains. It is transmitted sexually from the infected person or from the infected pregnant woman to the baby.
Browse More Details @ https://www.marketdataforecast.com/market-reports/zika-virus-vaccines-market-6024/
There are different types of vaccines developing in order to provide protection against zika virus such as mRNA vaccines, DNA-based vaccines, genetically engineered vaccines and inactivated vaccines. With the rise in zika virus incidences, many pharmaceutical and biotechnology companies are investing in this market. In very rare case, zika virus is also transmitted through blood transfusion. In 2016, the World Health Organization (WHO) declared that the major cases of zika virus were asymptomatic.
Factors like rising incidences of zika virus, growing people awareness about zika infection, high investment by private companies in the R&D of zika virus, serious attention due to high risk to the pregnant women, favourable government reimbursements, potential demand for zika vaccine and technology advancements in the healthcare industry are driving the Global Zika Virus Vaccines market. However, lack of awareness among the people and WHO announcing it as epidemic where is projected to have less potential in coming days is hindering the market growth.
The Global Zika Virus Vaccines Market is segmented on the basis of the vaccine type, end-user and region. On the basis of vaccine type, the market is segmented into therapeutic vaccines and preventive vaccines. Based on the end-user, the market is segmented into hospitals, clinics, research institutes and others. On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Latin America is expected to have the largest share followed by the Middle-East and Africa. This is due to more than 20 countries in Latin America have reported the high incidences of zika virus infection mainly Brazil, Columbia and Venezuela. Asia-Pacific is anticipated to have the fastest growing rate with highest CAGR during the forecast period.
Free Sample of the Report is available @ https://www.marketdataforecast.com/market-reports/zika-virus-vaccines-market-6024/request-sample
Major companies dominating the Global Zika virus vaccines market is Takeda Pharmaceutical Co. Ltd., NewLink Genetics Co., Immunovaccine Inc., GeneOne Life Science Inc., GlaxoSmithKline plc., Inovio Pharmaceuticals, Inc., Bharat Biotech International Ltd., Hawaii Biotech Inc. and Sanofi S.A.
Market Segmentation:
1) Type
Introduction
Therapeutic Vaccines
Preventive Vaccines
2) End-user
Introduction
Hospitals
Clinics
Research institutes
Scope of the Report:
Global, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms Clinics, Research Institutes, Others with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Make an Inquiry before buying @ https://www.marketdataforecast.com/market-reports/zika-virus-vaccines-market-6024/inquire
About us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
